113 related articles for article (PubMed ID: 37579716)
1. Construction of a genomic instability-derived predictive prognostic signature for non-small cell lung cancer patients.
Li W; Wu H; Xu J
Cancer Genet; 2023 Nov; 278-279():24-37. PubMed ID: 37579716
[TBL] [Abstract][Full Text] [Related]
2. Construction and evaluation of a prognostic risk model of tumor metastasis-related genes in patients with non-small cell lung cancer.
Ding H; Shi L; Chen Z; Lu Y; Tian Z; Xiao H; Deng X; Chen P; Zhang Y
BMC Med Genomics; 2022 Sep; 15(1):187. PubMed ID: 36056349
[TBL] [Abstract][Full Text] [Related]
3. A Genomic Instability-Associated Prognostic Signature for Glioblastoma Patients.
Chen X; Tian F; Wu Z
World Neurosurg; 2022 Nov; 167():e515-e526. PubMed ID: 35977679
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of somatic mutator-derived and immune infiltrates related lncRNA signatures of genome instability reveals potential prognostic biomarkers involved in non-small cell lung cancer.
Yang CZ; Yang T; Liu XT; He CF; Guo W; Liu S; Yao XH; Xiao X; Zeng WR; Lin LZ; Huang ZY
Front Genet; 2022; 13():982030. PubMed ID: 36226174
[No Abstract] [Full Text] [Related]
5. Identification and Validation of a Tumor Microenvironment-Related Gene Signature for Prognostic Prediction in Advanced-Stage Non-Small-Cell Lung Cancer.
Zhang X; Shi X; Zhao H; Jia X; Yang Y
Biomed Res Int; 2021; 2021():8864436. PubMed ID: 33860055
[TBL] [Abstract][Full Text] [Related]
6. A robust six-gene prognostic signature for prediction of both disease-free and overall survival in non-small cell lung cancer.
Zuo S; Wei M; Zhang H; Chen A; Wu J; Wei J; Dong J
J Transl Med; 2019 May; 17(1):152. PubMed ID: 31088477
[TBL] [Abstract][Full Text] [Related]
7. A prognostic model of non small cell lung cancer based on TCGA and ImmPort databases.
Yang D; Ma X; Song P
Sci Rep; 2022 Jan; 12(1):437. PubMed ID: 35013450
[TBL] [Abstract][Full Text] [Related]
8. Characterization of genomic instability-related genes predicts survival and therapeutic response in lung adenocarcinoma.
Li S; Wang W; Yu H; Zhang S; Bi W; Sun S; Hong B; Fang Z; Chen X
BMC Cancer; 2023 Nov; 23(1):1115. PubMed ID: 37974107
[TBL] [Abstract][Full Text] [Related]
9. Six CT83-related Genes-based Prognostic Signature for Lung Adenocarcinoma.
Wang Y; Zhang G; Wang R
Comb Chem High Throughput Screen; 2022; 25(9):1565-1575. PubMed ID: 34259140
[TBL] [Abstract][Full Text] [Related]
10. The signature based on seven genomic instability-related genes could predict the prognosis of acute myeloid leukemia patients.
Nie L; Zhang Y; You Y; Lin C; Li Q; Deng W; Ma J; Luo W; He H
Hematology; 2022 Dec; 27(1):840-848. PubMed ID: 35924822
[TBL] [Abstract][Full Text] [Related]
11. Bioinformatics analysis and experimental validation of TTK as a biomarker for prognosis in non-small cell lung cancer.
Chen J; Wu R; Xuan Y; Jiang M; Zeng Y
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 32969465
[TBL] [Abstract][Full Text] [Related]
12. Establishment of non-small-cell lung cancer risk prediction model based on prognosis-associated ADME genes.
Han K; Wang J; Qian K; Zhao T; Zhang Y
Biosci Rep; 2021 Oct; 41(10):. PubMed ID: 34522968
[TBL] [Abstract][Full Text] [Related]
13. Identifying the hub genes in non-small cell lung cancer by integrated bioinformatics methods and analyzing the prognostic values.
Wang T; Chen X; Jing F; Li Z; Tan H; Luo Y; Shi H
Pathol Res Pract; 2021 Dec; 228():153654. PubMed ID: 34749208
[TBL] [Abstract][Full Text] [Related]
14. An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma.
Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Xie Y
Front Med (Lausanne); 2022; 9():925661. PubMed ID: 35872794
[TBL] [Abstract][Full Text] [Related]
15. A innovative prognostic symbol based on neutrophil extracellular traps (NETs)-related lncRNA signature in non-small-cell lung cancer.
Fang C; Liu F; Wang Y; Yuan S; Chen R; Qiu X; Qian X; Zhang X; Xiao Z; Wang Q; Fu B; Li Y
Aging (Albany NY); 2021 Jul; 13(13):17864-17879. PubMed ID: 34257164
[TBL] [Abstract][Full Text] [Related]
16. A somatic mutation-derived LncRNA signatures of genomic instability predicts the prognosis and tumor microenvironment immune characters in hepatocellular carcinoma.
Jin C; Zhao JS; Huang XQ; Yang XZ; Niu FY; Lin JR; Ma L; Shi YX; Li XS; Jiang P; Gao S; Li F; Song Y
Hepatol Int; 2022 Oct; 16(5):1220-1233. PubMed ID: 35947245
[TBL] [Abstract][Full Text] [Related]
17. Construction and validation of an aging-related gene signature predicting the prognosis of pancreatic cancer.
Wang D; Zhang Y; Wang X; Zhang L; Xu S
Front Genet; 2023; 14():1022265. PubMed ID: 36741321
[No Abstract] [Full Text] [Related]
18. Construction of a redox-related gene signature for overall survival prediction and immune infiltration in non-small-cell lung cancer.
Miao TW; Yang DQ; Gao LJ; Yin J; Zhu Q; Liu J; He YQ; Chen X
Front Mol Biosci; 2022; 9():942402. PubMed ID: 36052170
[No Abstract] [Full Text] [Related]
19. Prognostic characterization of immune molecular subtypes in non-small cell lung cancer to immunotherapy.
Li C; Pan J; Luo J; Chen X
BMC Pulm Med; 2021 Nov; 21(1):389. PubMed ID: 34844602
[TBL] [Abstract][Full Text] [Related]
20. Construction of a prognostic model for lung squamous cell carcinoma based on immune-related genes.
Pu J; Teng Z; Yang W; Zhu P; Zhang T; Zhang D; Wang B; Hu Z; Song Q
Carcinogenesis; 2023 May; 44(2):143-152. PubMed ID: 36455238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]